o-Tolidine
|
CAS
119-93-7
|
C14H16N2
|
RTECS
DD1225000
|
Synonyms & Trade Names
4,4'-Diamino-3,3'-dimethylbiphenyl; Diaminoditolyl; 3,3'-Dimethylbenzidine; 3,3'-Dimethyl-4,4'-diphenyldiamine; 3,3'-Tolidine
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL: Ca C 0.02 mg/m3 [60-minute] [skin] See Appendix A See Appendix C
|
|
OSHA PEL: See Appendix C
|
IDLH
Ca [N.D.]
See: IDLH INDEX
|
Conversion
|
Physical Description
White to reddish crystals or powder. [Note: Darkens on exposure to air. Often used in paste or wet cake form. Used as a basis for many dyes.]
|
MW: 212.3
|
BP: 572°F
|
MLT: 264°F
|
Sol: 0.1%
|
VP: ?
|
IP: ?
|
|
Sp.Gr: ?
|
Fl.P: ?
|
UEL: ?
|
LEL: ?
|
|
|
Combustible Solid
|
Incompatibilities & Reactivities
Strong oxidizers
|
Measurement Methods
NIOSH 5013; OSHA 71
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated/Daily
Remove: When wet or contaminated
Change: Daily
Provide: Eyewash, Quick drench
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap flush immediately
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
NIOSH
At concentrations above the NIOSH REL, or where there is no REL, at any detectable concentration:
(APF = 10,000) Any self-contained breathing apparatus that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode
(APF = 10,000) Any supplied-air respirator that has a full facepiece and is operated in a pressure-demand or other positive-pressure mode in combination with an auxiliary self-contained positive-pressure breathing apparatus
Escape:
(APF = 50) Any air-purifying, full-facepiece respirator (gas mask) with a chin-style, front- or back-mounted organic vapor canister having an N100, R100, or P100 filter. Click here for information on selection of N, R, or P filters./Any appropriate escape-type, self-contained breathing apparatus
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, nose; in animals: liver, kidney damage; [potential occupational carcinogen]
|
Target Organs
Eyes, respiratory system, liver, kidneys
Cancer Site
[in animals: liver, bladder & mammary gland tumors]
|
|
See also: INTRODUCTION
See ICSC CARD: 0960 |
